Compassionate Use of REGEN|COV

Accessing unproven interventions in the COVID-19 pandemic

Since the onset of the SARS-CoV-2 pandemic, an array of off-label interventions has been used to treat patients, either provided as compassionate care or tested ...

Efficacy and safety of a single dose of casirivimab and imdevimab ...

Stein, D ∙ Oviedo-Orta, E ∙ Kampman, WA ∙ et al. Compassionate use of REGEN-COV® in patients with COVID-19 and immunodeficiency-associated antibody disorders.

Making It Count: Extracting Real World Data from Compassionate ...

In a time characterized by two very different viral pathogens, misinformation and SARS-CoV ... Characterizing expanded access and compassionate ...

Treating COVID-19—Off-Label Drug Use, Compassionate Use, and ...

coronavirus in humans, including SARS-CoV-2. Numer- ous drugs that have been highly promising in vitro for other infectious diseases have failed in clinical ...

Compassionate Use of Remdesivir for Patients With Severe Covid-19

The authors present a case of late initiation of remdesivir antiviral therapy in the successful treatment of a patient with SARS-CoV-2 in a ...

Compassionate Use Open-Label Anti-CD14 Treatment in Patients ...

The binding of IC14 to human CD14 prevents CD14 from participating in the recognition of PAMPs and DAMPs due to SARS-CoV-2 infection. The ...

Expanded Access to Investigational Therapies for Cancer

A complete listing of clinical trials by all sponsors, including ImmunityBio, can be found at clinicaltrials.gov. ... Compassionate Use access may be of benefit ...

Compassionate access and emergency use

Also known as compassionate use or a single patient IND, refers to the use of an investigational (not FDA approved) drug/device to diagnose, monitor or treat a ...

Casirivimab-imdevimab neutralizing SARS-CoV-2: post-infusion ...

Only one patient receiving oxygen supply (1.0%) failed to meet the entry criteria [1] for compassionate use. Table 1 Profile of background ...

Regeneron's Antibodies and Gilead's Remdesivir Explained

... treatment for SARS-CoV-2. Remdesivir advanced to Phase III in July ... The FDA allows “expanded access” (also called “compassionate use ...

Paid Family and Medical Leave (PFML) overview and benefits

Official websites use .mass.gov. A .mass.gov website belongs to an official government organization in Massachusetts. Secure websites use HTTPS certificate. A ...

Compassionate use of remdesivir in children with COVID-19

A nationwide multicenter observational study was conducted on children with confirmed SARS-CoV-2 receiving compassionate treatment with RDV in Spain.

Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19

The symptoms caused by SARS-CoV-2 vary from mild respiratory symptoms to severe pneumonia and acute respiratory distress syndrome (ARDS), ...

Off label, compassionate and irrational use of medicines in Covid-19 ...

When mankind was struck by the pandemic, there was no antiviral drug of proven efficacy against SARS-CoV-2, nor were there evidence-based guidance and protocols ...

Results of Compassionate-Use Remdesivir for Severe COVID-19

Remdesivir, an inhibitor of viral RNA polymerase, has activity against SARS-CoV-2 (the cause of COVID-19) in vitro and against other ...

EMA recommendations on compassionate use of remdesivir for ...

Remdesivir is an RNA polymerase inhibitor that has shown activity against SARS-CoV-2, the coronavirus causing the COVID-19 pandemic, SARS-CoV ...

DPS Services - the Texas Department of Public Safety

Compassionate Use Program. | Available Online. Contact Crime Records Service ... texas.gov · The 1836 Project: Telling the Texas Story. Feedback. Customer ...

Emergency Medical Services (EMS) - Wake County Government

Prompt, Compassionate, Clinically Excellent Care ... Wake County Department of Emergency Medical Services is responsible for providing paramedic level EMS ...

FloridaHealthFinder

The Florida Agency for Health Care Administration (AHCA) created healthfinder.fl.gov to provide easy access to health care information.

Physicians and Surgeons : Occupational Outlook Handbook

Physicians and surgeons, at https://www.bls.gov/ooh/healthcare/physicians-and-surgeons.htm (visited September 26, 2024).